NASDAQ Shariah screener · October 2026
Is Kimberly-Clark Corporation (KMB) Halal?
Kimberly-Clark Corporation · NASDAQ: KMB · Consumer Staples
The short answer
Yes — Kimberly-Clark (KMB) passes this Shariah stock screen. The American consumer-staples company (Huggies, Kleenex, Scott, Kotex, Cottonelle, Depend; sold in 175+ countries) has no prohibited business lines. Interest-bearing debt from continuing operations of $6,517 million is about 19.9% of its ~$32.7 billion market cap (332.6M shares at ~$94.34, Oct 2, 2026), below the ~33% ceiling. Interest income of $9 million for H1 2026 is about 0.11% of net sales ($8,352 million), far below the 5% non-compliant income ceiling. Zoya rates KMB Shariah-compliant and Musaffa classifies it halal (both as of October 2026); no ShariaPortfolio coverage was found — honestly reported as absent, not invented.
Gate 1 — Business activity: PASS
Kimberly-Clark Corporation (NASDAQ: KMB) is an American consumer-staples company manufacturing personal care and tissue products sold in more than 175 countries. Its brand portfolio includes Huggies (diapers and baby care), Kleenex (facial tissue), Cottonelle and Scott (toilet paper and paper towels), Kotex and Poise (feminine care), Depend (adult care), Pull-Ups, GoodNites, Andrex, and WypAll professional products. It reports through two segments — North America and International Personal Care — after selling a 51% interest in its International Family Care and Professional business to Suzano on July 1, 2026 (the Arbex joint venture, now reported as discontinued operations). Its pending acquisition of Kenvue (consumer health) remains on track to close by the end of 2026. None of the disclosed lines — personal care, tissue, adult care, professional wipes — are prohibited lines (no alcohol, gambling, pork, conventional banking/insurance, tobacco, cannabis, weapons, or adult entertainment). Gate 1 passes. Facts only.
Gate 2 — Debt and cash: PASS
At June 30, 2026 the company's interest-bearing debt from continuing operations was $6,517 million — $43 million of debt payable within one year plus $6,474 million of long-term debt — down from $7.2 billion at December 31, 2025, per the Q2 2026 condensed consolidated balance sheet. Against a market capitalization of about $32.7 billion (about 332.6 million shares outstanding at roughly $94.34, Finnhub, October 2, 2026), debt ÷ market cap is about 19.9%, below the ~33% ceiling. Cash and cash equivalents from continuing operations of $956 million are about 2.9% of market cap, within the ~33% guideline. The debt gate passes; discontinued-operations liabilities of the divested IFP business are reported separately and excluded. Facts only.
Gate 3 — Non-compliant income: PASS
Interest income was $9 million for the six months ended June 30, 2026 (Q2 2026: $4 million; Q1 2026: $5 million), disclosed as a separate line in the condensed consolidated statements of income (the same format used in the SEC 10-Q), against net sales of $8,352 million — about 0.11% of revenue, far below the 5% non-compliant income limit. For context, the FY2025 annual report (ended December 31, 2025) shows interest income of $24 million — about 0.14% of revenue per Zoya's annual-report read. The interest is earned on cash and time deposits, not from lending. On both the interim and annual basis, Gate 3 passes. Facts only.
Key figures used
- Business: US consumer-staples maker of personal care and tissue — Huggies, Kleenex, Cottonelle, Scott, Kotex, Poise, Depend, Pull-Ups, WypAll; 175+ countries; segments North America + International Personal Care
- Corporate changes 2026: 51% of International Family Care and Professional business sold to Suzano on Jul 1, 2026 (Arbex JV, now discontinued operations); pending Kenvue acquisition (~$6.7B cash + ~280M shares) expected to close by end of 2026
- Interest-bearing debt: $6,517M at Jun 30, 2026 ($43M short-term + $6,474M long-term, continuing ops) — debt ÷ market cap ≈ 19.9% of ~$32.7B, under the ~33% ceiling; down from $7.2B at Dec 31, 2025
- Cash: $956M cash and cash equivalents (continuing) ≈ 2.9% of market cap, within the ~33% guideline
- Interest income: $9M (H1 2026) vs net sales $8,352M — ≈0.11% of revenue, far under the 5% non-compliant income ceiling; FY2025 interest income $24M ≈ 0.14% per annual report
- H1 2026: net sales $8.4B (+1.6%); operating profit $1.4B (+13.3%); Q2 diluted EPS from continuing ops $1.22
- Listing: transferred from NYSE to Nasdaq on May 30, 2025 (ticker unchanged: KMB)
- Zoya covers KMB — rates it Shariah-compliant (Oct 2026); Musaffa covers KMB — classifies it halal (Oct 2026, AAOIFI); no ShariaPortfolio coverage found — reported as absent, not invented
Frequently asked questions
What does Kimberly-Clark do?
Kimberly-Clark Corporation (NASDAQ: KMB) is an American consumer-staples company that makes personal care and tissue products sold in more than 175 countries. Its brands include Huggies diapers and baby care, Kleenex facial tissue, Cottonelle and Scott toilet paper and paper towels, Kotex and Poise feminine and adult care, Depend adult care, Pull-Ups and GoodNites youth products, and WypAll professional wipes. It reports through two segments: North America and International Personal Care. On July 1, 2026 it completed the sale of a 51% interest in its International Family Care and Professional business to Suzano (the Arbex joint venture) and now reports that business as discontinued operations. Its pending acquisition of Kenvue remains on track to close by the end of 2026. None of the disclosed business lines are prohibited lines.
Why does Kimberly-Clark pass this Shariah stock screen?
Kimberly-Clark's business has no prohibited lines — personal care and tissue products (Huggies, Kleenex, Scott, Kotex, Cottonelle, Depend) involve no alcohol, gambling, pork, conventional banking or insurance, tobacco, cannabis, weapons, or adult entertainment. Its financial structure passes: total debt from continuing operations of $6,517 million is about 19.9% of its roughly $32.7 billion market cap, below the ~33% ceiling, and cash of $956 million is about 2.9% of market cap. Its non-compliant income also passes: interest income of $9 million for the first half of 2026 is about 0.11% of net sales ($8,352 million), far below the 5% non-compliant income ceiling. This is a factual screen, not a religious ruling — consult a qualified scholar for personal guidance.
What is Kimberly-Clark's interest-bearing debt ratio?
At June 30, 2026 Kimberly-Clark's interest-bearing debt from continuing operations was $6,517 million — $43 million of debt payable within one year plus $6,474 million of long-term debt — down from $7.2 billion at December 31, 2025. Against a market capitalization of about $32.7 billion (about 332.6 million shares at roughly $94.34, Finnhub, October 2, 2026), debt ÷ market cap is about 19.9%, below the ~33% ceiling. Cash and cash equivalents from continuing operations of $956 million are about 2.9% of market cap, within the ~33% guideline. The debt gate passes; the debt figure excludes discontinued-operations liabilities of the divested International Family Care and Professional business, which the company reports separately.
What is Kimberly-Clark's non-compliant income ratio?
For the six months ended June 30, 2026, Kimberly-Clark reported interest income of $9 million (Q2 2026: $4 million; Q1 2026: $5 million) against net sales of $8,352 million — about 0.11% of revenue, far below the 5% non-compliant income limit. The interest-income line is disclosed separately in the company's condensed consolidated statements of income, the same format used in its SEC 10-Q filings. For context, Zoya cites the FY2025 annual report (ended December 31, 2025) with interest income of $24 million on revenue of $17,216 million — about 0.14%. On both the interim and annual basis used here, the income gate passes.
Do Zoya, Musaffa, or ShariaPortfolio cover Kimberly-Clark?
Zoya covers Kimberly-Clark (zoya.finance/stocks/kmb): as of October 2026 it rates KMB Shariah-compliant, citing the FY2025 annual report with interest income of $24 million (about 0.14% of revenue). Musaffa also covers Kimberly-Clark (musaffa.com/stock/KMB/): as of October 2026 it classifies KMB as halal under its AAOIFI-based screening methodology. No coverage of Kimberly-Clark was found on ShariaPortfolio — honestly reported as absent, not invented. This page applies the screen directly from the company's filings: the August 4, 2026 Q2/FY-half press release (reproducing the Q2 2026 10-Q condensed consolidated statements of income and balance sheet).
Sources
- Kimberly-Clark — Q2/FY-half 2026 press release (PRNewswire, Aug 4, 2026): condensed consolidated statements of income (H1 net sales $8,352M; interest income $9M) and balance sheet (cash $956M; debt payable within one year $43M; long-term debt $6,474M; 332.6M shares outstanding); IFP 51% sale to Suzano Jul 1, 2026; pending Kenvue acquisition
- Kimberly-Clark — NYSE to Nasdaq listing transfer announcement (May 19, 2025): common stock ceased trading on NYSE May 29, 2025; commenced Nasdaq trading May 30, 2025; ticker unchanged
- Finnhub — KMB market data (market cap $32.70B, price $94.34, Oct 2, 2026)
- Zoya — KMB stock page: rates Kimberly-Clark Shariah-compliant (Oct 2026); cites FY2025 annual report revenue $17,216M and interest income $24M (0.14%)
- Musaffa — KMB stock page: classifies Kimberly-Clark as halal (Oct 2026), AAOIFI methodology
Screened 2026-10-02 from published company figures and market data. Figures change; this page is educational, not financial advice and not a religious ruling.
Screened with our two-gate Shariah screening methodology (business-activity gate, then AAOIFI-style financial ratios).